1Life Healthcare Inc. [ONEM] stock for 6,753 USD was sold by Agarwal Vikas

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. 1Life Healthcare Inc. shares valued at $6,753 were sold by Agarwal Vikas on Aug 15. At $17.14 per share, Agarwal Vikas sold 394 shares. The insider’s holdings dropped to 5,851 shares worth approximately $0.1 million following the completion of this transaction.


Top 5 Cheap Stocks to Own Right Now

While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.

Sign up here to get your free report now.

Sponsored


As published in a research note from Deutsche Bank on July 12, 2022, 1Life Healthcare Inc. [ONEM] has been rated down from a Buy to a Hold and the price target has been revised to $12 from $11. This represents a -42.75% premium over Wednesday’s closing price. Analysts at Evercore ISI downgraded the stock from ‘”an Outperform”‘ to ‘”an In-line”‘ outlook in a report released in mid July. As of July 07, 2022, BTIG Research has increased its “Neutral” rating to a “Buy” for ONEM. Earlier on May 27, 2022, Stifel initiated its rating. Their recommendation was “a Buy” for ONEM stock.

Analyzing ONEM’s Price Performance

The stock’s lowest price that day was $17.06, but it reached a high of $17.23 in the same session. During the last five days, there has been a drop of approximately -0.41%. Over the course of the year, 1Life Healthcare Inc. shares have dropped approximately -2.50%. Shares of the company reached a 52-week high of $18.43 on 01/04/22 and a 52-week low of $5.94 on 05/12/22. A 50-day SMA is recorded $16.25, while a 200-day SMA reached $12.18. Nevertheless, trading volume fell to 3.06 million shares from 4.63 million shares the previous day.

Support And Resistance Levels for 1Life Healthcare Inc. (ONEM)

According to the 24-hour chart, there is a support level at 17.05, which, if violated, would cause prices to drop to 16.97. In the upper region, resistance lies at 17.22. The next price resistance is at 17.31. RSI (Relative Strength Index) is 58.17 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.04, which suggests the price will decrease in the coming days. Percent R is at 57.90%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Is 1Life Healthcare Inc. subject to short interest?

Stocks of 1Life Healthcare Inc. saw a sharp rise in short interest on Jul 14, 2022 jumping by 0.39 million shares to 15.97 million. Data from Yahoo Finance shows that the short interest on Jun 14, 2022 was 15.58 million shares. A jump of 2.44% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 5.14 of the overall float, the days-to-cover ratio (short ratio) jumped to 5.14.

Which companies own the most shares of 1Life Healthcare Inc. (ONEM)?

According to Tiger Global Management LLC filings, the company currently owns 16,986,234 shares, which is about 8.70% of the total ONEM shares outstanding. The investor’s shares have plunged by -687,000 from its previous 13-F filing of 17673234.0 shares. With the completion of the buy transaction, The Vanguard Group, Inc.’s stake is now worth $273,425,149. BlackRock Fund Advisors acquire a 38.60% interest valued at $207.58 million while Fidelity Management & Research Co sold a -593,087 stake. A total of -202,026 shares of 1Life Healthcare Inc. were sold by ARK Investment Management LLC during the quarter, and 1,116,990 were bought by Redmile Group LLC. In its current portfolio, Newton Investment Management Nort holds 4,484,638 shares valued at $77.18 million.

In terms of 1Life Healthcare Inc. share price expectations, FactSet research, analysts set an average price target of $17.91 in the next 12 months, up nearly 5.08% from the previous closing price of $17.13. Analysts anticipate 1Life Healthcare Inc. stock to reach $18.00 by 2022, with the lowest price target being $16.90. In spite of this, 14 analysts ranked 1Life Healthcare Inc. stock as a Hold at the end of 2022. On April 01, 2022, Credit Suisse assigned a price target of “an Outperform” to the stock and resumed coverage with a $15.

LEAVE A REPLY

Please enter your comment!
Please enter your name here